Association between the Fatty Liver Index, Metabolic Dysfunction-Associated Steatotic Liver Disease, and the Risk of Kidney Stones
被引:0
|
作者:
Zhang, Fan
论文数: 0引用数: 0
h-index: 0
机构:
Xuzhou Med Univ, Changzhou Clin Coll, Changzhou, Peoples R China
Changzhou Third Peoples Hosp, Dept Endocrinol, Changzhou, Peoples R China
Changzhou Third Peoples Hosp, Dept Clin Nutr, Changzhou, Peoples R ChinaXuzhou Med Univ, Changzhou Clin Coll, Changzhou, Peoples R China
Zhang, Fan
[1
,2
,3
]
Li, Wenjian
论文数: 0引用数: 0
h-index: 0
机构:
Xuzhou Med Univ, Changzhou Clin Coll, Changzhou, Peoples R China
Changzhou Third Peoples Hosp, Dept Urol, Changzhou, Peoples R ChinaXuzhou Med Univ, Changzhou Clin Coll, Changzhou, Peoples R China
Li, Wenjian
[1
,4
]
机构:
[1] Xuzhou Med Univ, Changzhou Clin Coll, Changzhou, Peoples R China
[2] Changzhou Third Peoples Hosp, Dept Endocrinol, Changzhou, Peoples R China
[3] Changzhou Third Peoples Hosp, Dept Clin Nutr, Changzhou, Peoples R China
[4] Changzhou Third Peoples Hosp, Dept Urol, Changzhou, Peoples R China
Introduction: This study aimed to investigate the potential association between the fatty liver index (FLI), metabolic dysfunction-associated steatotic liver disease (MASLD), and the risk of kidney stones using large-scale population-based data. Methods: This study employed a cross-sectional design, utilizing data from the 2007 to 2018 National Health and Nutrition Examination Survey (NHANES) database. A total of 24,342 participants were enrolled in the study, and fatty liver status was assessed by calculating the FLI. MASLD was diagnosed by FLI in conjunction with cardiometabolic criteria. Data on the history of kidney stones were obtained by self-report. We employed logistic regression models to analyze the association between FLI, MASLD, and kidney stone risk and constructed multivariable adjustment models to control for potential confounders. Furthermore, we used restricted cubic spline curve models to investigate the dose-response relationship between FLI and kidney stone risk and conducted subgroup and interaction analyses. Results: The study's results indicate a strong correlation between increasing FLI quartiles and a notable rise in the prevalence of kidney stones. Specifically, the risk of developing kidney stones was 1.68 times higher among participants in the highest FLI quartile compared to those in the lowest. Furthermore, patients with MASLD exhibited a 1.35-fold increased risk of developing kidney stones compared to those with non-MASLD. Subgroup analyses demonstrated that the correlation between MASLD and kidney stone risk was consistent across multiple subgroups. However, a significant interaction was observed in the subgroups of smoking status, physical activity level, and hypertension (interaction p < 0.05). The restricted cubic spline analysis did not yield a statistically significant nonlinear association between FLI and kidney stone risk. However, the study did identify inflection point values for FLI. Conclusion: This study demonstrated an association between FLI and MASLD and the risk of kidney stones. This suggests that these conditions may be pivotal risk factors for kidney stones. Further investigation is required to elucidate these associations' underlying mechanisms and develop efficacious interventions to reduce the risk of kidney stones. Also, formulating personalized prevention and treatment strategies for different population subgroups is paramount.
机构:
Karolinska Inst, Dept Med, Stockholm, SwedenKarolinska Inst, Dept Med, Stockholm, Sweden
Astrom, Hanne
Takami Lageborn, Christine
论文数: 0引用数: 0
h-index: 0
机构:
Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, SwedenKarolinska Inst, Dept Med, Stockholm, Sweden
Takami Lageborn, Christine
Hagstrom, Hannes
论文数: 0引用数: 0
h-index: 0
机构:
Karolinska Inst, Dept Med, Stockholm, Sweden
Karolinska Univ Hosp, Dept Upper GI, Div Hepatol, Stockholm, SwedenKarolinska Inst, Dept Med, Stockholm, Sweden
机构:
Univ South China, Affiliated Nanhua Hosp, Hlth Management Ctr, Hengyang, Peoples R ChinaUniv South China, Affiliated Nanhua Hosp, Hlth Management Ctr, Hengyang, Peoples R China
Wang, Jingwei
Zhao, Jinli
论文数: 0引用数: 0
h-index: 0
机构:
Univ South China, Sch Pharmaceut Sci, Hengyang, Peoples R ChinaUniv South China, Affiliated Nanhua Hosp, Hlth Management Ctr, Hengyang, Peoples R China
Zhao, Jinli
Zhong, Yueyuan
论文数: 0引用数: 0
h-index: 0
机构:
Univ South China, Affiliated Nanhua Hosp, Hlth Management Ctr, Hengyang, Peoples R ChinaUniv South China, Affiliated Nanhua Hosp, Hlth Management Ctr, Hengyang, Peoples R China
Zhong, Yueyuan
He, Chengyue
论文数: 0引用数: 0
h-index: 0
机构:
Hengyang Normal Univ, Sch Marxism, Hengyang, Peoples R ChinaUniv South China, Affiliated Nanhua Hosp, Hlth Management Ctr, Hengyang, Peoples R China
He, Chengyue
Hu, Fen
论文数: 0引用数: 0
h-index: 0
机构:
Univ South China, Affiliated Nanhua Hosp, Hlth Management Ctr, Hengyang, Peoples R ChinaUniv South China, Affiliated Nanhua Hosp, Hlth Management Ctr, Hengyang, Peoples R China
机构:
St Elizabeths Med Ctr, Tufts Sch Med, Dept Med, Boston, MA 02111 USASt Elizabeths Med Ctr, Tufts Sch Med, Dept Med, Boston, MA 02111 USA
Razzak, Iyiad Alabdul
Noureddin, Mazen
论文数: 0引用数: 0
h-index: 0
机构:
Houston Res Inst, Houston, TX 77030 USA
Houston Methodist Hosp, Houston, TX 77030 USASt Elizabeths Med Ctr, Tufts Sch Med, Dept Med, Boston, MA 02111 USA
Noureddin, Mazen
Trivedi, Hirsh D.
论文数: 0引用数: 0
h-index: 0
机构:
Cedars Sinai Med Ctr, Comprehens Transplant Ctr, Los Angeles, CA 90048 USA
Cedars Sinai Med Ctr, Karsh Div Gastroenterol, Los Angeles, CA 90048 USASt Elizabeths Med Ctr, Tufts Sch Med, Dept Med, Boston, MA 02111 USA
机构:
Univ Calif San Diego, MASLD Res Ctr, Div Gastroenterol & Hepatol, La Jolla, CA USA
Univ Calif San Diego, Div Gastroenterol & Hepatol, La Jolla, CA USA
Univ Calif San Diego, Sch Publ Hlth, La Jolla, CA USA
Univ Calif San Diego, Div Gastroenterol & Hepatol, La Jolla, CA 92093 USAUniv Calif San Diego, MASLD Res Ctr, Div Gastroenterol & Hepatol, La Jolla, CA USA
Loomba, Rohit
Wong, Vincent Wai-Sun
论文数: 0引用数: 0
h-index: 0
机构:
Chinese Univ Hong Kong, Med Data Analyt Ctr, Dept Med & Therapeut, Hong Kong, Peoples R China
Chinese Univ Hong Kong, Inst Digest Dis, State Key Lab Digest Dis, Hong Kong, Peoples R ChinaUniv Calif San Diego, MASLD Res Ctr, Div Gastroenterol & Hepatol, La Jolla, CA USA
机构:
Sichuan Univ, West China Hosp, Lab Gastroenterol & Hepatol, Chengdu 610041, Peoples R China
Sichuan Univ, West China Hosp, Dept Gastroenterol, Chengdu 610041, Peoples R ChinaSichuan Univ, West China Hosp, Lab Gastroenterol & Hepatol, Chengdu 610041, Peoples R China
Chen, Jiaxin
Jian, Linge
论文数: 0引用数: 0
h-index: 0
机构:
Sichuan Univ, West China Hosp, Lab Gastroenterol & Hepatol, Chengdu 610041, Peoples R China
Sichuan Univ, West China Hosp, Dept Gastroenterol, Chengdu 610041, Peoples R ChinaSichuan Univ, West China Hosp, Lab Gastroenterol & Hepatol, Chengdu 610041, Peoples R China
Jian, Linge
Guo, Yangkun
论文数: 0引用数: 0
h-index: 0
机构:
Sichuan Univ, West China Hosp, Lab Gastroenterol & Hepatol, Chengdu 610041, Peoples R China
Sichuan Univ, West China Hosp, Dept Gastroenterol, Chengdu 610041, Peoples R ChinaSichuan Univ, West China Hosp, Lab Gastroenterol & Hepatol, Chengdu 610041, Peoples R China
Guo, Yangkun
Tang, Chengwei
论文数: 0引用数: 0
h-index: 0
机构:
Sichuan Univ, West China Hosp, Lab Gastroenterol & Hepatol, Chengdu 610041, Peoples R China
Sichuan Univ, West China Hosp, Dept Gastroenterol, Chengdu 610041, Peoples R ChinaSichuan Univ, West China Hosp, Lab Gastroenterol & Hepatol, Chengdu 610041, Peoples R China
Tang, Chengwei
Huang, Zhiyin
论文数: 0引用数: 0
h-index: 0
机构:
Sichuan Univ, West China Hosp, Lab Gastroenterol & Hepatol, Chengdu 610041, Peoples R ChinaSichuan Univ, West China Hosp, Lab Gastroenterol & Hepatol, Chengdu 610041, Peoples R China
Huang, Zhiyin
Gao, Jinhang
论文数: 0引用数: 0
h-index: 0
机构:
Sichuan Univ, West China Hosp, Lab Gastroenterol & Hepatol, Chengdu 610041, Peoples R China
Sichuan Univ, West China Hosp, Dept Gastroenterol, Chengdu 610041, Peoples R ChinaSichuan Univ, West China Hosp, Lab Gastroenterol & Hepatol, Chengdu 610041, Peoples R China